Work

SUBDUE-3: Sub-urothelial durvalumab-sirconium to investigate local and systemic distribution of durvalumab when injected in the sub-urothelium.

Year: 2025

Type: article

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.5_suppl.tps903

Authors: Kevin Keane, Andrisha Jade Inderjeeth, Roslyn J. Francis, Andrew Mark Scott, Cynthia Hawks, Richard Gauci, Ian D. Davis, Andrew David Redfern, Dickon Hayne

Institutions: The University of Western Australia, Sir Charles Gairdner Hospital, Olivia Newton-John Cancer Research Institute, Australian and New Zealand Urogenital and Prostate Cancer Trials Group, South Metropolitan Health Service, Eastern Health, Monash University

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7093308360

FWCI: 0.869

Cites:

Cited by: 1

Related to: